Table 1.
Patient clinical data
| Patients Characteristics | N patients (n = 25) | % | P |
|---|---|---|---|
| Median age | 60 | – | – |
| Male | 11/25 | 44% | – |
| Deaths | 19/25 | 76% | – |
| Primary | |||
| Pancreatic | 15/25 | 60% | – |
| Ileal | 9/25 | 36% | – |
| Lung | 1/25 | 4% | – |
| Grading | |||
| NET G1 | 5/25 | 20% | – |
| NET G2 | 19/25 | 76% | – |
| NET G3 | 1/25 | 4% | – |
| Overall PFS Median | 15 months | – | – |
| Overall OS Median | 21 months | – | – |
| PFS ≤ 11 (n = 10/25) | PFS > (n = 15/25) | |||
|---|---|---|---|---|
| PFS Median | 4.5 months | PFS Median | 25 months | 0.009 |
| OS Median | 13 | OS Median | 29 | 0.08 |
| Deaths | 8 | Deaths | 11 | |
Bold value denotes statistical significance
*PFS Progression-free survival, OS Overall survival